index - Myasthenia Gravis: étiologie, physiopathologie & approches thérapeutiques Accéder directement au contenu

Dernières publications

Chiffres clés

Chargement de la page

Open Access

46 %

Mots clés

LMNA Immune regulation Thymic epithelial cells Myasthénie grave Th17 cells Exercise Gender Endogenous nucleic acids Antimir-150 FMR1 Inflammation Genetic associations Disease susceptibility Aldehyde dehydrogenase biological marker CD31 antigen CD34 antigen CD45 antigen CD56 antigen adipocyte animal experiment animal model animal tissue antigen expression article cell differentiation cell function cell isolation cell labeling cell population cell selection controlled study endomysium enrichment culture enzyme activity enzyme substrate flow cytometry human human cell human tissue immunofluorescence in vitro study in vivo study mouse muscle biopsy muscle contraction muscle injury nonhuman phenotype skeletal muscle stem cell transplantation Adipogenesis Aldehyde Dehydrogenase Cell Differentiation Cells Cultured Flow Cytometry Humans Immunohistochemistry Muscle Cells Muscle Development Muscle Skeletal Phenotype Fragile X syndromes Immune response BAFF Interferon type I Myoblasts Etiology CTCF Chronicity Immunology and Microbiology Section Centres germinatifs ectopiques Animal models COX2 Immunity Anticorps monoclonal Experimental autoimmune myasthenia gravis Early-onset myasthenia gravis Chronic inflammation Myasthenia Gravis MG Thymus Gd T cells Interferon CD31 Acetylcholine receptor antibodies Cardiomyopathy Chemokine Conduction disease Interferon IFN Genetics Experimental models M3243AG Germinal center Inflammatory cytokines Innate immunity Acetylcholine receptor Interferon type-I Autoimmune diseases Acides nucléiques endogènes Ectopic germinal centers Macrophages Immunotherapy Interféron de type I B cells Adaptive immunity AChR antibodies Maladie auto-immune Human myoblasts DICER Interferonopathy Thymoma Germinal centers Ferrites Quality of life Clinical cell transplantation Il-23 Myasthenia gravis CCL21 PBMC Experimental autoimmune myasthenia gravis EAMG CXCL13-CXCR5 Acetylcholine receptors Complete Freund's adjuvant MiR-125 MYB MiR-7 Autoimmunity Cytokines Neuromuscular junction MG patients Transcriptome Chemokines Experimental mouse models Glucocorticoids Interferon-β COVID-19 Long-term follow-up Interleukine-23 Auto-immunité Heart failure Autoimmune disease Autoimmunity Inflammation Neuromuscular junction Germinal centers Th17 Muscle regeneration Cellules th17 Mass cytometry CyTOF Max Interferon de type I Lamin A/C nuclei Interleukin 23